Furudate A, Hirose S, Abe K, Kawashima A, Hashimoto K, Yamazaki S, Kamei K, Ishiwada N, Hamada H, Sato M: Infantile Aspergillus fumigatus ventriculitis successfully treated with monitoring of plasma and cerebrospinal fluid voriconazole concentration level. J Infect Chemother., 2020 Jan;26(1):132-135. doi: 10.1016/j.jiac.2019.06.011. Epub 2019 Jul 23.
Arai S, Ishikawa T, Kato H, Koshizaka M, Maezawa Y, Nakamura T, Suzuki T, Yokote K, Ishii I: Multidrug use positively correlates with high-risk prescriptions in the Japanese elderly: a longitudinal study. J Pharm Health Care Sci. 2019 Sep 2;5:20. doi: 10.1186/s40780-019-0150-6.
Lazarova D, Shibata S, Ishii I, Zlateva G, Zhelevf Z, Aokib I, Bakalovaa R: Imaging of redox-imbalance and oxidative stress in kidney in vivo, induced by dietary cholesterol. Biotechnol. Biotechnol. Equip. doi.org/10.1080/13102818.2019.1573153, 2019.
Lazarov D, Shibata S, Ishii I, Zlateva G, Zhelev Z, Aoki I, Higashi T, Rumiana Bakalova: Nitroxide-enhanced magnetic resonance imaging of kidney dysfunction in vivo based on redox-imbalance and oxidative stress. Gen. Physiol. Biophys, 38:191-204, 2019.
Igari H, Yamagishi K, Yamazaki S, Murata S, Yahaba M, Takayanagi S, Kawasaki Y, Taniguchi T: Epidemiology and treatment outcome of pneumonia: Analysis based on Japan national database. J Infect Chemother, 2020 Jan;26(1):58-62. doi: 10.1016/j.jiac.2019.07.001.
Izumi-Nakaseko H, Fujiyosh M, Hagiwara-Nagasawa M, Goto A, Chiba K, Kambayashi R, Nait AT, Ando K, Kanda Y, Ishii I, Sugiyama A: Dasatinib can Impair Left Ventricular Mechanical Function But May Lack Proarrhythmic Effect: A Proposal of Non‑clinical Guidance for Predicting Clinical Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors. Cardiovasc Toxicol, 2019, doi.org/10.1007/s12012-019-09538-5
Ishikawa M, Yamazaki S, Suzuki T, Uchida M, Iwadate Y, Ishii I: Correlation between vancomycin penetration into cerebrospinal fluid and protein concentration in cerebrospinal fluid/serum albumin ratio. J Infect Chemother, 25(2): 124-128, 2019.
Yamazaki K, Ariyoshi N, Miyauchi H, Ohira G, Kaneya N, Yamamoto K, Arai K, Yamazaki S, Matsubara H, Suzuki T, Ishii I: A randomized controlled, open-label early phase II trial comparing incidence of FOLFIRI.3-induced diarrhea between Hangeshashinto and oral alkalization in Japanese patients with colorectal cancer. J Clin Pharm Ther. Dec;44(6):946-951, 2019.
Takachi T, Arakawa Y, Nakamura H, Watanabe T, Aoki Y, Ohshima J, Takahashi Y, Hirayama M, Miyamura T, Sugita K, Koh K, Horibe K, Ishii E, Mizutani S, Tomizawa D: Personalized pharmacokinetic targeting with busulfan in allogeneic hematopoietic stem cell transplantation in infants with acute lymphoblastic leukemia. Int J Hematol. Sep;110(3):355-363, 2019.
Suzuki Tas, Suzuki Tak, Takatsuka H, Yamazaki S, Ishii I: Successful treatment of seizure disorder by evaluating phenobarbital clearance in a paediatric patient undergoing continuous haemodiafiltration. J Clin Pharm Ther. 44(3):479-481, 2019.
Hiromi Kaneko, Kiyoshi Shikino, Takako Nakamura, Takaaki Suzuki, Masatomi Ikusaka, Itsuko Ishii: Differences between physicians and pharmacists in the clinical reasoning process to adverse drug reactions, 79th FIP World Congress of Pharmacy and Pharmaceutical Sciences, アブダビ(2019.9.22-26).